Zogenix, Inc.
(NASDAQ : ZGNX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.31%173.280.4%$142.79m
JAZZJazz Pharmaceuticals Plc
0.70%177.282.2%$125.36m
SAGESAGE Therapeutics, Inc.
-0.35%167.429.6%$116.12m
PRGOPerrigo Co. Plc
-0.55%76.006.7%$93.00m
ENDPEndo International Plc
0.26%11.248.9%$75.76m
MNKMallinckrodt Plc
0.99%22.0421.1%$73.47m
ICPTIntercept Pharmaceuticals, Inc.
0.43%96.0921.8%$69.04m
ZGNXZogenix, Inc.
-1.27%58.4511.9%$67.87m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.06%148.976.8%$63.42m
CTLTCatalent Inc
0.46%43.382.6%$62.40m
SUPNSupernus Pharmaceuticals, Inc.
-1.10%54.106.3%$40.45m
MDCOMedicines Company
0.60%40.0021.8%$39.33m
PTLAPortola Pharmaceuticals, Inc.
0.13%40.157.7%$37.37m
UTHRUnited Therapeutics Corporation
0.77%124.0814.4%$37.00m
AERIAerie Pharmaceuticals, Inc.
1.02%74.357.9%$32.20m

Company Profile

Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.